Related Experiment Videos
Optimal stent design for drug delivery.
1Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Reviews in Cardiovascular Medicine
|June 9, 2004
Summary
Drug-eluting coronary stents utilize advanced materials for controlled drug delivery. Innovations include bioabsorbable coatings and novel drug compounds to improve efficacy and safety in cardiovascular treatment.
Area of Science:
- Cardiovascular medicine
- Biomaterials science
- Pharmacology
Background:
- Drug-eluting stents (DES) are crucial in treating coronary artery disease.
- Efficacy and safety of DES vary based on drug agents and delivery systems.
- Research is exploring stent backbone, drug-delivery vehicles, and drug properties.
Purpose of the Study:
- To review constituents of drug-delivery stents.
- To highlight advancements in drug-eluting stent technology.
- To discuss novel materials and drug release mechanisms.
Main Methods:
- Analysis of current research on DES components.
- Review of polymer coatings (bioabsorbable and non-bioabsorbable).
- Examination of drug-loading and release strategies.
Main Results:
- Polymer coatings enable controlled and sustained drug delivery.
- Non-bioabsorbable phosphorylcholine polymer releases ABT-578 (sirolimus analogue).
- Bioabsorbable polylactic acid coating on cobalt-chromium alloy for drug encapsulation.
Conclusions:
- Next-generation DES incorporate advanced polymers and drug analogues.
- Novel stent designs aim for optimized drug-tissue interaction and therapeutic outcomes.
- Tailored material and drug combinations promise improved cardiovascular interventions.